Fundviser Capital (India) Limited (BOM:530197)
240.00
-2.15 (-0.89%)
At close: Jan 21, 2026
Fundviser Capital (India) Revenue
Fundviser Capital (India) had revenue of 444.89M INR in the quarter ending September 30, 2025, with 89,959.11% growth. This brings the company's revenue in the last twelve months to 946.88M, up 22,327.25% year-over-year. In the fiscal year ending March 31, 2025, Fundviser Capital (India) had annual revenue of 332.84M with 3,318.32% growth.
Revenue (ttm)
946.88M
Revenue Growth
+22,327.25%
P/S Ratio
1.54
Revenue / Employee
157.81M
Employees
6
Market Cap
1.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 332.84M | 323.11M | 3,318.32% |
| Mar 31, 2024 | 9.74M | 7.52M | 339.51% |
| Mar 31, 2023 | 2.22M | 500.40K | 29.18% |
| Mar 31, 2022 | 1.72M | -6.62M | -79.43% |
| Mar 31, 2021 | 8.34M | 5.44M | 187.77% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Modern Engineering and Projects | 1.15B |
| Trans India House Impex | 606.33M |
| Kabra Drugs | 269.14M |
| Maha Rashtra Apex Corporation | 81.31M |
| Pratik Panels | 52.98M |
| Transchem | 26.30M |
| ZR2 Bioenergy | 201.00K |
| ASL Industries | -236.56K |